Palotai, Miklos http://orcid.org/0000-0003-0268-6977
Nazeri, Aria
Cavallari, Michele
Healy, Brian C.
Glanz, Bonnie
Gold, Stefan M. http://orcid.org/0000-0001-5188-4799
Weiner, Howard L.
Chitnis, Tanuja
Guttmann, Charles R. G.
Article History
Received: 17 April 2019
Accepted: 12 September 2019
First Online: 14 October 2019
Competing Interests
: M.P., A.N. and M.C. report no disclosures. B.C.H. was on the Biogen Worldwide Medical Biostatistics Multiple Sclerosis Advisory Board and received grant support from Genzyme, Merck Serono, Novartis, and Verily Life Sciences. S.M.G. reports honoraria from Almirall S.A., Mylan, and Celgene and research support from Biogen and GAIA group. He has received research funding from Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung and the National MS Society (NMSS). B.G. received research support from Merck Serono and Verily Life Sciences. H.L.W. reports grants from National Institutes of Health, National Multiple Sclerosis Society, Verily Life Sciences, Genentech, Inc., Google Life Sciences, EMD Serono, Inc., Biogen, Teva Pharmaceuticals, and Novartis; grants and consulting from Sanofi US Services, Inc.; consulting and advising from Tilos Therapeutics; consulting and advising from Tiziana Life Sciences; consulting and advising from IM Therapeutics; personal fees, consulting and advising from vTv Therapeutics; personal fees, consulting and advising from MedDay Pharmaceuticals. T.C. is a consultant at Biogen, Novartis and Roche-Genetech and serves on advisory boards for pediatric clinical trials for Novartis and Genzyme-Sanofi and received research support from Serono, Biogen, Novartis and Verily Life Sciences. C.R.G. has received a grant from Sanofi and a grant from the National Multiple Sclerosis Society, and has received funding from the International Progressive Multiple Sclerosis Alliance.